Two Diseases-One Preclinical Treatment Targeting Glycogen Synthesis.
作者信息
Gentry Matthew S, Markussen Kia H, Donohue Katherine J
机构信息
Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY, USA.
出版信息
Neurotherapeutics. 2022 Apr;19(3):977-981. doi: 10.1007/s13311-022-01240-9. Epub 2022 Apr 22.
Abstract
摘要
相似文献
1
Two Diseases-One Preclinical Treatment Targeting Glycogen Synthesis.
Neurotherapeutics. 2022 Apr;19(3):977-981. doi: 10.1007/s13311-022-01240-9. Epub 2022 Apr 22.
2
Targeting Gys1 with AAV-SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models.
Neurotherapeutics. 2021 Apr;18(2):1414-1425. doi: 10.1007/s13311-021-01040-7. Epub 2021 Apr 8.
3
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency.
Neuropathol Appl Neurobiol. 2022 Feb;48(1):e12761. doi: 10.1111/nan.12761. Epub 2021 Sep 12.
4
Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.
Cell Rep. 2019 Apr 30;27(5):1334-1344.e6. doi: 10.1016/j.celrep.2019.04.017.
5
Update on polyglucosan storage diseases.
Virchows Arch. 2019 Dec;475(6):671-686. doi: 10.1007/s00428-019-02633-6. Epub 2019 Jul 30.
6
Glycogen hyperphosphorylation underlies lafora body formation.
Ann Neurol. 2010 Dec;68(6):925-33. doi: 10.1002/ana.22156.
7
Sensitive quantification of α-glucans in mouse tissues, cell cultures, and human cerebrospinal fluid.
J Biol Chem. 2020 Oct 23;295(43):14698-14709. doi: 10.1074/jbc.RA120.015061. Epub 2020 Aug 13.
8
Role of Astrocytes in the Pathophysiology of Lafora Disease and Other Glycogen Storage Disorders.
Cells. 2023 Feb 24;12(5):722. doi: 10.3390/cells12050722.
9
Polyglucosan storage myopathies.
Mol Aspects Med. 2015 Dec;46:85-100. doi: 10.1016/j.mam.2015.08.006. Epub 2015 Aug 13.
10
Glycogen metabolism in tissues from a mouse model of Lafora disease.
Arch Biochem Biophys. 2007 Jan 15;457(2):264-9. doi: 10.1016/j.abb.2006.10.017. Epub 2006 Nov 3.
引用本文的文献
1
Zebrafish navigating the metabolic maze: insights into human disease - assets, challenges and future implications.
J Diabetes Metab Disord. 2024 Dec 16;24(1):3. doi: 10.1007/s40200-024-01539-8. eCollection 2025 Jun.
2
Case report: Expanding the understanding of the adult polyglucosan body disease continuum: novel presentations, diagnostic pitfalls, and clinical pearls.
Front Genet. 2023 Dec 18;14:1282790. doi: 10.3389/fgene.2023.1282790. eCollection 2023.
3
Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model.
Neurotherapeutics. 2023 Oct;20(6):1808-1819. doi: 10.1007/s13311-023-01434-9. Epub 2023 Sep 12.
本文引用的文献
1
Inhibiting glycogen synthesis prevents Lafora disease in a mouse model.
Ann Neurol. 2013 Aug;74(2):297-300. doi: 10.1002/ana.23899.
Zotero 插件